Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126962382 | 12696238 | 2 | F | 20160905 | 20160829 | 20160907 | EXP | DE-ROCHE-1821511 | ROCHE | PRIVACY. ANALYSIS OF CARDIOVASCULAR DISEASES AFTER THE UPLOAD PHASE WITH INTRAVITREAL RANIBIZUMAB AND BEVACIZUMAB IN PATIENTS WITH EXUDATIVE AGE- RELATED MACULAR DEGENERATION. DER OPHTHALMOLOGE 2016 ;:-. | 0.00 | E | M | Y | 0.00000 | 20160907 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126962382 | 12696238 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | UNK | 125156 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126962382 | 12696238 | 1 | Neovascular age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126962382 | 12696238 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126962382 | 12696238 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |